Barclays »

Nurix Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $698k 48k 14.69
2023-12-31 $709k 69k 10.31
2023-09-30 $530k 68k 7.86
2023-06-30 $690k 69k 10.00
2023-03-31 $642k 72k 8.90
2022-12-31 $1.1M 100k 10.98
2022-09-30 $1.1M 85k 13.03
2022-06-30 $34k 2.7k 12.58
2022-03-31 $72k 5.2k 13.90